The effect of an App for cell phones and tablets on the blood glucose of elderly people with Type 2 Diabetes

Not Applicable

• Conditions: Diabetes Mellitus, Type 2; C18.452

• Registration Number: RBR-8ywgvm8
• Lead Sponsor: niversidade de Brasília - Faculdade de Ceilândia

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-11-21
• Last Update Posted: 29 May 2023
• Study Completion: 2023-10-04

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: Not specified
• Target Recruitment: Not specified

Inclusion Criteria

Elderly aged between 60 and 75 years of both sexes; literate; access to electronic mobile devices; Internet access; medical diagnosis of type 2 diabetes for at least one year; use of oral medication for type 2 diabetes; able to have independence and autonomy to perform activities of daily living that will be measured by the Barthel index; in need of adaptation or supervision by third parties to carry out activities of daily living; who do not practice physical activity or who have insufficient physical activity, assessed using the International Physical Activity Questionnaire (IPAQ) short version

Exclusion Criteria

Elderly people using insulin; with multiple chronic comorbidities such as cancer, rheumatoid arthritis, congestive heart failure, severe depression, emphysema, Parkinson's disease, myocardial infarction, stroke, class III chronic renal failure or worse, end-stage disease such as metastatic cancer, class 4- 5, chronic lung disease requiring oxygen therapy, dialysis patients, severe functional and cognitive impairment; participants in another clinical trial, research study, or exercise program in which they perform similar balance and strength activities; have mobility limitations or use walking devices; diagnosis of progressive neurological disease or other acute or unstable medical condition that prevents exercise; cardiac risk classification II, III and IV according to the New York Heart Association (NYHA) Functional Classification

Study & Design

• Study Type: Intervention
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
It is expected that the intervention group, after using the intervention for 3 months (application for mobile devices), will have a 1.0% reduction in glycated hemoglobin (HbA1c). The HbA1c will be checked by means of a blood test in the pre (up to 30 days before the intervention) and in the post-intervention (up to 30 days after the intervention).